MYX mayne pharma group limited

Net Debt and Cash Flow The Company ended the year with net debt...

  1. 7,284 Posts.
    lightbulb Created with Sketch. 447
    Net Debt and Cash Flow

    The Company ended the year with net debt of $303m. Cash on hand at 31 December 2017 was $56m and the Company had borrowings of $359m. The Company achieved positive net operating cash flow after interest, tax, working capital and oneoff items of $48.0m. Significant cash flow items during the period include $39.5m in capital expenditure, $23.2m payments for product development (expensed and capitalised), $17.8m in earn-out payments, $6.8m in net tax payments, $6.9m in net interest and a $8.8m working capital release
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.20
Change
0.000(0.00%)
Mkt cap ! $422.4M
Open High Low Value Volume
$5.29 $5.29 $5.17 $1.533M 294.1K

Buyers (Bids)

No. Vol. Price($)
1 3000 $5.20
 

Sellers (Offers)

Price($) Vol. No.
$5.29 4126 2
View Market Depth
Last trade - 16.10pm 10/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.